-  Faculty Experts   -  News by Topic   -  News by School Search News & Info WUSTL in the News   - Powered by Google WUSTL Home Public Affairs Home University News Medical News Sports News Radio Service Business, Law & Econ Culture & Living Science & Technology Contact Information TV/Radio Studio Visiting Our Campuses Campus Images Sports photography Commercial Filming    and Photography Commercial Use of    Names and Symbols Domain Name policy Record (newspaper) Campus Calendars WUSTL News Summary Publications Online Facts, Guides & Maps		Washington University in St. Louis News & Information > Faculty Experts at Washington University in St. Louis > David Piwnica-Worms Director, Molecular Imaging Center Expertise: Molecular imaging, non-invasive imaging, MRI, PET, bioluminescence, luciferase, gene expression Bio: David Piwinica-Worms, who is professor of radiology and of molecular biology and pharmacology, leads an innovative program at the Molecular Imaging Center that is dedicated to devising new non-invasive ways to analyze and monitor many different biological processes in living tissue. The imaging and scanning technologies that Piwnica-Worms and his colleagues employ include PET scans, MRI imaging and bioluminescence. Their overall goal is to advance the understanding of biology and medicine through noninvasive in vivo investigation of gene expression and molecular interactions in the context of the whole organism. Education: M.D. at Duke University Ph.D. in Duke University News Stories & Tip Sheets: Showing 3 Stories. Viewing cancer at the molecular level Innovative molecular imaging center gets five-year, $10 million renewal grant Nov. 8, 2007 -- An innovative cancer imaging center at the School of Medicine has received a five-year, $10 million grant from the National Cancer Institute (NCI). The grant will fund a second cycle of research at the Washington University Molecular Imaging Center, where scientists from many different specialties collaborate on advanced imaging projects. Clearing brain plaque Molecular drug pump may help reduce risk of Alzheimer's Oct. 20, 2005 -- A molecule that has long been an obstacle to cancer chemotherapy and drug treatments for brain disorders may soon become an ally in the fight against Alzheimer's disease, according to researchers at the School of Medicine and the University of Rochester. Lighting the way Firefly protein lets researchers monitor molecule linked to cancer Aug. 8, 2005 -- Scientists have used a glowing protein from fireflies to observe the activity of a molecule that is an important target for new drugs to treat cancer, autoimmune diseases and several other disorders. Showing 3 Stories.			Related Information Media Assistance: Michael Purdy Senior Medical Sciences Writer purdym@wustl.edu (314) 286-0122 Related Groups: Schools: • School of Medicine Departments: • Radiology - View All Groups Related Topics: • Medical Science - View All Topics Revised: Monday, Aug. 15, 2005   Email this page   Print ready page Subscribe WUSTL News by E-mail
News & Information  |   Medical News  |   Office of Public Affairs  |   WUSTL Home Please contact us and let us know how we can assist you. Technical problems with this Web site? Email questions or comments. Please review the WUSTL News & Information copyright/privacy policy.